Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

NCT03526861 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Tralokinumab
DRUG: Placebos

Sponsor

LEO Pharma